Metabolic dysfunction–associated steatotic liver disease (MASLD), a replacement of the
nomenclature employed for NAFLD, is the most prevalent chronic liver disease worldwide …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder worldwide. It
comprises a spectrum of conditions that range from steatosis to non-alcoholic …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent type
of liver disease worldwide. The exact pathophysiology behind MASLD remains unclear; …

The pathogenesis of non-alcoholic fatty liver disease (NAFLD), the most common global
liver disease, is complex as multiple parallel hits drive this disorder. Whereas lipotoxicity …

Diet and lifestyle are crucial factors that influence the susceptibility of humans to
nonalcoholic fatty liver disease (NAFLD). Personalized diet patterns chronically affect the …

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as
nonalcoholic fatty liver disease (NAFLD), is associated with altered gut microbiota; however …

Background Non-alcoholic fatty liver (NAFLD) is a common, multi-factorial, and poorly
understood liver disease whose incidence is globally rising. NAFLD is generally …

Non‐alcoholic fatty liver disease (NAFLD) is the major cause of chronic liver disease
worldwide as a consequence of a sedentary lifestyle and overnutrition. NAFLD could …

The correlation between gut, secreted metabolites, and hepatic diseases has strengthened
over the last decade. Interactions of intestinal permeability, gut microbes, and derived …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. NAFLD begins as a relatively benign hepatic steatosis which can evolve to non …